Your session is about to expire
← Back to Search
Withdrawal Regulation Training for Smoking Cessation
Phase 3
Recruiting
Research Sponsored by University of Alabama at Birmingham
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
at least 18 years of age
Be older than 18 years old
Must not have
current use of any pharmacotherapy for smoking cessation
concurrent participation in a formal treatment program for smoking cessation
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months after end-of-treatment
Awards & highlights
No Placebo-Only Group
Pivotal Trial
Summary
This trial will test a new smoking cessation treatment to see if it is effective and how it works. The results could help improve existing treatments and reduce smoking-related deaths in the US.
Who is the study for?
This trial is for adults over 18 who smoke at least 5 cigarettes a day, want to quit, and live in the Birmingham area without plans to move. They must have access to a phone and show certain levels of carbon monoxide in their breath. People using other quit-smoking drugs or treatments, with conditions that make quitting harder or riskier, or with serious health issues can't join.
What is being tested?
The study tests new ways to help people stop smoking by teaching them cognitive-behavioral strategies for managing withdrawal symptoms and exposing them early on to these symptoms. It also includes relaxation techniques as part of the intervention.
What are the potential side effects?
Since this trial focuses on behavioral strategies rather than medication, there are no direct side effects like those from drugs. However, participants may experience increased stress or anxiety due to withdrawal symptom exposure.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 years old or older.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am currently using medication to help me stop smoking.
Select...
I am currently in a program to help me stop smoking.
Select...
I do not have any immediately life-threatening illnesses.
Select...
I have a health issue that prevents me from using nicotine patches.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months after end-of-treatment
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months after end-of-treatment
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Smoking cessation as evaluated by self-reported, biochemically-confirmed seven-day point-prevalence abstinence
Secondary study objectives
Abstinence-related expectancies
Cessation milestones as determined by the Timeline Followback Interview
Smoke
+4 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Pivotal Trial
The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
Trial Design
4Treatment groups
Experimental Treatment
Active Control
Group I: Early Withdrawal Exposure plus NAW Regulation TrainingExperimental Treatment2 Interventions
The development, application, modification, and repeated practice of individualized withdrawal regulation strategies (e.g., behavioral and cognitive strategies for allaying withdrawal symptoms) across the first 4 hours of abstinence over 4 separate sessions.
Group II: NAW Regulation Training OnlyActive Control1 Intervention
The development, application, modification, and repeated practice of individualized withdrawal regulation strategies (e.g., behavioral and cognitive strategies for allaying withdrawal symptoms) over 4 separate sessions involving smoking as usual.
Group III: Early Withdrawal Exposure plus Relaxation Control TrainingActive Control2 Interventions
The development, application, modification, and repeated practice of relaxation strategies across the first 4 hours of abstinence over 4 separate sessions.
Group IV: Relaxation Control Training OnlyActive Control1 Intervention
The development, application, modification, and repeated practice of relaxation strategies over 4 separate sessions involving smoking as usual.
Find a Location
Who is running the clinical trial?
University of Alabama at BirminghamLead Sponsor
1,640 Previous Clinical Trials
2,331,690 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am currently using medication to help me stop smoking.I don't have any health issues that would make following the study rules hard.You cannot speak or understand English.I am currently in a program to help me stop smoking.I am 18 years old or older.I do not have any immediately life-threatening illnesses.You smoke at least 5 cigarettes every day.I have a health issue that prevents me from using nicotine patches.You have expressed a desire to stop participating in the study.
Research Study Groups:
This trial has the following groups:- Group 1: NAW Regulation Training Only
- Group 2: Early Withdrawal Exposure plus Relaxation Control Training
- Group 3: Early Withdrawal Exposure plus NAW Regulation Training
- Group 4: Relaxation Control Training Only
Awards:
This trial has 2 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger